Ann Arbor, MI, United States of America

Jeffrey Thomas Kohrt


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jeffrey Thomas Kohrt

Introduction

Jeffrey Thomas Kohrt is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target thrombotic disorders. With a total of two patents to his name, Kohrt's work is recognized for its potential impact on medical treatments.

Latest Patents

Kohrt's latest patents focus on inhibitors of factor Xa and other serine proteases involved in the coagulation cascade. The present invention provides compounds of Formula (I), wherein A, B, C, G, and W have any of the values defined in the specification, and pharmaceutically acceptable salts thereof. These compounds are useful for treating thrombotic disorders. Additionally, the patents disclose pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing these compounds, and intermediates useful for their preparation.

Career Highlights

Throughout his career, Kohrt has worked with prominent companies, including Pfizer Corporation. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Some of his notable coworkers include Christopher Franklin Bigge and Agustin Casimiro-Garcia. Their collaborative efforts have contributed to the advancement of research and development in their field.

Conclusion

Jeffrey Thomas Kohrt's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of thrombotic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…